共 50 条
- [41] PHASE II TRIAL OF FIRST-LINE CAPECITABINE PLUS OXALIPLATIN IN PATIENTS WITH METASTATIC NASOPHARYNGEAL CARCINOMAANNALS OF ONCOLOGY, 2010, 21 : 324 - 324Chua, D.论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R China Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R ChinaNg, W. T.论文数: 0 引用数: 0 h-index: 0机构: Pamela Youde Nethersole Eastern Hosp, Chaiwan, Hong Kong, Peoples R China Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R ChinaNg, W. Y.论文数: 0 引用数: 0 h-index: 0机构: Tuen Mun Hosp, Tuen Mun, Hong Kong, Peoples R China Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R ChinaLui, C. Y.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Kwai Chung, Hong Kong, Peoples R China Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R ChinaLi, V.论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R China Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R ChinaCheng, A.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Kwai Chung, Hong Kong, Peoples R China Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R China
- [42] Clinical outcomes with first-line chemotherapy versus endocrine therapy for adjuvant endocrine therapy-resistant metastatic breast cancerTRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 676 - 685Shao, Bin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaYang, Yanlian论文数: 0 引用数: 0 h-index: 0机构: CAS Ctr Excellence Nanosci, Natl Ctr Nanosci & Technol, CAS Key Lab Standardizat & Measurement Nanotechno, Beijing 100190, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaQu, Jinrong论文数: 0 引用数: 0 h-index: 0机构: Shijiazhuang Third Hosp, Dept Oncol & Hematol, Shijiazhuang 050011, Hebei, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaLi, Huiping论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaSong, Guohong论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaDi, Lijun论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaJiang, Hanfang论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaYan, Ying论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaWang, Huan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaLiu, Xiaoran论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaWang, Jing论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R ChinaKong, Weiyao论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Med Oncol,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China
- [43] Avelumab First-Line Maintenance Therapy: Managing Patients With Advanced Urothelial CarcinomaCLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (01) : 71 - 80Lapuente, Maria论文数: 0 引用数: 0 h-index: 0机构: Bartholomews Hosp, London, England Bartholomews Hosp, London, EnglandConway, Dawn论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago Med Illinois, Genitourinary Oncol, Chicago, IL USA Bartholomews Hosp, London, EnglandWood, Laura S.论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin Ohio, Taussig Canc Ctr, Cleveland, OH USA Bartholomews Hosp, London, EnglandKehoe, Kiran论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY USA Bartholomews Hosp, London, EnglandBullock, Andrea Carroll论文数: 0 引用数: 0 h-index: 0机构: North Amer Med Commun EMD Serono, Rockland, MA, Brazil Bartholomews Hosp, London, EnglandDevgan, Geeta论文数: 0 引用数: 0 h-index: 0机构: Pfizer, US Med Affairs, New York, NY USA Bartholomews Hosp, London, EnglandBurns, Kathleen D.论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, Natl Canc Ctr, Duarte, CA USA Bartholomews Hosp, London, England
- [44] Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in ChinaBMJ OPEN, 2023, 13 (12):Zhao, Ziying论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Prov Chest Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Henan Prov Chest Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R ChinaChen, Tongfeng论文数: 0 引用数: 0 h-index: 0机构: Fuwai Cent China Cardiovasc Hosp, Henan Prov Peoples Hosp, Henan Res Ctr Cardiovasc Epidemiol, Dept Struct Heart Dis,Heart Ctr,Henan Key Lab Coro, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Henan Prov Chest Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R ChinaZhou, Zhen论文数: 0 引用数: 0 h-index: 0机构: Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia Zhengzhou Univ, Henan Prov Chest Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R ChinaGuo, Rui论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Prov Chest Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R China Zhengzhou Univ, Henan Prov Chest Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R ChinaLiu, Qiao论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China Zhengzhou Univ, Henan Prov Chest Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R China
- [45] First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinomaLUNG CANCER, 2019, 137 : 100 - 107Lin, Zuan论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Ctr Canc, Dept Clin Res, Guangzhou, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaFu, Sha论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Cellular & Mol Diagnost Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaZhou, Yixin论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept VIP Reg, Ctr Canc, Guangzhou, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaZhang, Xuanye论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaChen, Chen论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept Radiotherapy, Ctr Canc, Guangzhou, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaHe, Li-na论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaLi, Haifeng论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaWang, Yuhong论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept Endoscopy, Ctr Canc, Guangzhou, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaChen, Tao论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept Nucl Med, Ctr Canc, Guangzhou, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaZhang, Li论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R ChinaHong, Shaodong论文数: 0 引用数: 0 h-index: 0机构: State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
- [46] Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal CarcinomaMOLECULAR THERAPY, 2014, 22 (01) : 132 - 139Chia, Whay-Kuang论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeTeo, Marissa论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeWang, Who-Whong论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeLee, Bernett论文数: 0 引用数: 0 h-index: 0机构: Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeAng, Soo-Fan论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeTai, Wai-Meng论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeChee, Chit-Lai论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeNg, Joanna论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeKan, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeLim, Wan-Teck论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeTan, Sze-Huey论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Res, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeOng, Whee-Sze论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Res, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeCheung, Yin-Bun论文数: 0 引用数: 0 h-index: 0机构: Duke NUS Grad Med Sch, Singapore, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeTan, Eng-Huat论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeConnolly, John E.论文数: 0 引用数: 0 h-index: 0机构: Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeGottschalk, Stephen论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Methodist Hosp, Texas Childrens Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, SingaporeToh, Han-Chong论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore
- [47] Prognostic factors for overall survival with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Patil, S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAFiglin, R. A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAHutson, T. E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAMichaelson, M. D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USANegrier, S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKim, S. T.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAHuang, X.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAMotzer, R. J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
- [48] Immunotherapy combined with chemotherapy improved clinical outcomes over bevacizumab combined with chemotherapy as first-line therapy in adenocarcinoma patientsCANCER MEDICINE, 2023, 12 (05): : 5352 - 5363Wang, Min论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China Shandong Acad Med Sci, Jinan, Shandong, Peoples R China Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R ChinaLi, Ji论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China Shandong Acad Med Sci, Jinan, Shandong, Peoples R China Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R ChinaXu, Shuhui论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China Shandong Acad Med Sci, Jinan, Shandong, Peoples R China Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R ChinaLi, Yuying论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China Shandong Acad Med Sci, Jinan, Shandong, Peoples R China Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R ChinaLi, Jiatong论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China Shandong Acad Med Sci, Jinan, Shandong, Peoples R China Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R ChinaYu, Jinming论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China Shandong Acad Med Sci, Jinan, Shandong, Peoples R China Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R ChinaTang, Xiaoyong论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Dept Radiat Oncol, Shandong Canc Hosp & Inst, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R ChinaZhu, Hui论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Dept Radiat Oncol, Shandong Canc Hosp & Inst, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
- [49] Clinical and Economic Outcomes in Patients With Metastatic Urothelial Carcinoma Receiving First-Line Systemic Treatment (the IMPACT UC I Study)ONCOLOGIST, 2023, 28 (09): : 790 - 798Bilen, Mehmet A.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Atlanta, GA USA Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA Emory Univ, Winship Canc Inst, Atlanta, GA USARobinson, Scott B.论文数: 0 引用数: 0 h-index: 0机构: Inovalon, Bowie, MD USA Emory Univ, Winship Canc Inst, Atlanta, GA USASchroeder, Amy论文数: 0 引用数: 0 h-index: 0机构: Avalere Hlth, Washington, DC USA Emory Univ, Winship Canc Inst, Atlanta, GA USAPeng, Jing论文数: 0 引用数: 0 h-index: 0机构: Avalere Hlth, Washington, DC USA Emory Univ, Winship Canc Inst, Atlanta, GA USAKim, Ruth论文数: 0 引用数: 0 h-index: 0机构: Pfizer, New York, NY USA Emory Univ, Winship Canc Inst, Atlanta, GA USALiu, Frank X.论文数: 0 引用数: 0 h-index: 0机构: EMD Serono Inc, Rockland, MA USA Emory Univ, Winship Canc Inst, Atlanta, GA USABhanegaonkar, Abhijeet论文数: 0 引用数: 0 h-index: 0机构: EMD Serono Inc, Rockland, MA USA EMD Serono Inc, Rockland, MA 02370 USA Emory Univ, Winship Canc Inst, Atlanta, GA USA
- [50] Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: A case reportJournal of Medical Case Reports, 11 (1)Marciano R.论文数: 0 引用数: 0 h-index: 0机构: Department of Clinical Medicine and Surgery, Oncology Division, University of Naples Federico II, Naples Department of Clinical Medicine and Surgery, Oncology Division, University of Naples Federico II, Naples论文数: 引用数: h-index:机构:Bianco C.论文数: 0 引用数: 0 h-index: 0机构: Department of Experimental and Clinical Medicine, University of Catanzaro Magna Grecia, Catanzaro Department of Clinical Medicine and Surgery, Oncology Division, University of Naples Federico II, NaplesBianco R.论文数: 0 引用数: 0 h-index: 0机构: Department of Clinical Medicine and Surgery, Oncology Division, University of Naples Federico II, Naples Department of Clinical Medicine and Surgery, Oncology Division, University of Naples Federico II, Naples